Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vijaya L Simhadri

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Frontiers in Medicine|May 24, 2021
HLA Variants and Inhibitor Development in Hemophilia A: A Retrospective Case-Controlled Study Using the ATHNdatasetJoseph R McGill, Vijaya L Simhadri, Zuben E Sauna
Gene Therapy|November 8, 2021
Endotoxin contamination in commercially available Cas9 proteins potentially induces T-cell mediated responsesVijaya L Simhadri, Joseph R McGill, Zuben E Sauna
Trends in Genetics : TIG|June 24, 2014
Exposing synonymous mutationsRyan C Hunt, Vijaya L Simhadri, Matthew Iandoli, et al.
Personalized Medicine|May 18, 2018
Personalized approaches to the treatment of hemophilia A and BVijaya L Simhadri, Aditi Sengupta Banerjee, Jonathan Simon, et al.
Molecular Therapy. Methods & Clinical Development|August 4, 2018
Prevalence of Pre-existing Antibodies to CRISPR-Associated Nuclease Cas9 in the USA PopulationVijaya L Simhadri, Joseph McGill, Shane McMahon, et al.
Nature Communications|August 25, 2021
Cas9-derived peptides presented by MHC Class II that elicit proliferation of CD4<sup>+</sup> T-cellsVijaya L Simhadri, Louis Hopkins, Joseph R McGill, et al.
F1000Research|February 25, 2017
Recent advances in (therapeutic protein) drug developmentH A Daniel Lagassé, Aikaterini Alexaki, Vijaya L Simhadri, et al.
Nature Communications|July 1, 2026
Pre-existing antibody and T cell responses to SaCas9, AsCas12a and CasΦ are comparable in naïve individualsVijaya L Simhadri, Pratima Bajgain, Sharon Vijayanand, et al.
Plos One|July 16, 2015
Small ncRNA Expression-Profiling of Blood from Hemophilia A Patients Identifies miR-1246 as a Potential Regulator of Factor 8 GeneTewarit Sarachana, Neetu Dahiya, Vijaya L Simhadri, et al.
The Journal of Biological Chemistry|November 13, 2012
Cyclosporin A impairs the secretion and activity of ADAMTS13 (a disintegrin and metalloprotease with thrombospondin type 1 repeat)Klilah Hershko, Vijaya L Simhadri, Adam Blaisdell, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Frontiers in Medicine|May 24, 2021
HLA Variants and Inhibitor Development in Hemophilia A: A Retrospective Case-Controlled Study Using the ATHNdatasetJoseph R McGill, Vijaya L Simhadri, Zuben E Sauna
Gene Therapy|November 8, 2021
Endotoxin contamination in commercially available Cas9 proteins potentially induces T-cell mediated responsesVijaya L Simhadri, Joseph R McGill, Zuben E Sauna
Trends in Genetics : TIG|June 24, 2014
Exposing synonymous mutationsRyan C Hunt, Vijaya L Simhadri, Matthew Iandoli, et al.
Personalized Medicine|May 18, 2018
Personalized approaches to the treatment of hemophilia A and BVijaya L Simhadri, Aditi Sengupta Banerjee, Jonathan Simon, et al.
Molecular Therapy. Methods & Clinical Development|August 4, 2018
Prevalence of Pre-existing Antibodies to CRISPR-Associated Nuclease Cas9 in the USA PopulationVijaya L Simhadri, Joseph McGill, Shane McMahon, et al.
Nature Communications|August 25, 2021
Cas9-derived peptides presented by MHC Class II that elicit proliferation of CD4<sup>+</sup> T-cellsVijaya L Simhadri, Louis Hopkins, Joseph R McGill, et al.
F1000Research|February 25, 2017
Recent advances in (therapeutic protein) drug developmentH A Daniel Lagassé, Aikaterini Alexaki, Vijaya L Simhadri, et al.
Nature Communications|July 1, 2026
Pre-existing antibody and T cell responses to SaCas9, AsCas12a and CasΦ are comparable in naïve individualsVijaya L Simhadri, Pratima Bajgain, Sharon Vijayanand, et al.
Plos One|July 16, 2015
Small ncRNA Expression-Profiling of Blood from Hemophilia A Patients Identifies miR-1246 as a Potential Regulator of Factor 8 GeneTewarit Sarachana, Neetu Dahiya, Vijaya L Simhadri, et al.
The Journal of Biological Chemistry|November 13, 2012
Cyclosporin A impairs the secretion and activity of ADAMTS13 (a disintegrin and metalloprotease with thrombospondin type 1 repeat)Klilah Hershko, Vijaya L Simhadri, Adam Blaisdell, et al.
Pageof 2